
US Patent No: 5,223,482
Number of patents in Portfolio can not be more than 2000
Recombinant Alzheimer's protease inhibitory amyloid protein and method of use
Stats
-
Jun 29, 1993
Issued date -
Jun 6, 1989
filing date -
07/361,912
serial no -
Expired
status
Importance
Loading Importance Indicators...
Abstract
DNA sequences encoding .beta.-amyloid-related proteins associated with Alzheimer's disease are disclosed. Also provided herein is a DNA sequence encoding a novel protease inhibitor. These sequences are used in producing or constructing recombinant .beta.-amyloid core protein, .beta.-amyloid-related proteins and recombinant or synthetic immunogenic peptides. Antibodies generated against the recombinant proteins or immunogenic peptides derived therefrom can be used for cerebral fluid or serum protein diagnosis of Alzheimer's disease.
Loading the Abstract Image...
First Claim
Related Publications
Loading Related Publications...
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art
| Patent Info | (Count) | # Cites | Year |
|---|---|---|---|
|
|
|||
| 4,595,674 Homologues of aprotinin with, in place of lysine, other aminoacids in position 15, process for their preparation and their use as medicaments | 43 | 1985 | |
|
|
|||
| 4,912,206 CDNA clone encoding brain amyloid of alzheimer's disease | 33 | 1987 | |
|
|
|||
| 4,666,829 Polypeptide marker for Alzheimer's disease and its use for diagnosis | 234 | 1985 | |